Asked by dick

How do mutations in DNA affect protein synthesis? Provide examples to support your thoughts.

All Answers 1

Answered by GPT-5 mini AI
Short answer
Mutations change the DNA sequence and so can change the mRNA and the encoded protein (or its amount). Depending on the type and location of the mutation, effects range from no change at all to altered amino acids, misfolding, truncated proteins, altered amounts of protein, or even new fusion proteins with novel activity.

How different mutations affect protein synthesis (with examples)

1) Point mutations (single base changes)
- Silent (synonymous): codon changes but still encodes the same amino acid. Usually no change in the protein sequence, but can sometimes alter mRNA stability, splicing, or translation speed.
- Example: many synonymous SNPs are neutral, though a well‑documented case (MDR1) shows a synonymous change can alter folding/functional properties by changing translation kinetics.
- Missense: codon changes to a different amino acid → altered protein sequence that may change function, stability, or folding.
- Example: Sickle cell anemia — a single base substitution in the β‑globin gene (HBB) changes glutamic acid to valine (Glu6→Val). The altered hemoglobin polymers under low oxygen and deforms red blood cells.
- Nonsense: codon changes to a stop codon → premature termination of translation → truncated protein, often nonfunctional and often degraded by nonsense‑mediated decay.
- Example: Some β‑thalassemia alleles are caused by nonsense mutations in the β‑globin gene that produce truncated, nonfunctional chains.

2) Insertions and deletions (indels)
- In-frame (multiples of 3 bases): remove or add whole amino acids but keep reading frame.
- Example: ΔF508 in CFTR (a deletion of three nucleotides removing phenylalanine at position 508) causes misfolding and ER retention of the CFTR chloride channel → cystic fibrosis.
- Frameshift (not a multiple of 3): changes the reading frame downstream → wrong amino acids and usually an early stop codon → severely altered or truncated protein.
- Example: Many Duchenne muscular dystrophy (DMD) mutations are frameshift deletions in the dystrophin gene that produce premature stops and essentially no functional dystrophin. In-frame deletions in the same gene can produce partly functional protein and a milder Becker muscular dystrophy.

3) Splice-site and regulatory mutations
- Splice-site mutations can cause exon skipping, intron retention, or use of cryptic splice sites → abnormal mRNA and protein.
- Example: Several β‑thalassemia alleles are splice-site mutations that disrupt normal β‑globin mRNA processing, reducing or abolishing β‑globin production.
- Promoter or enhancer mutations change transcription levels → too little or too much protein.
- Example: Mutations in promoter regions can lead to reduced expression of important genes; overexpression from regulatory changes can contribute to cancer.

4) Large-scale changes and rearrangements
- Deletions, duplications, or translocations can remove or fuse genes.
- Example: The Philadelphia chromosome t(9;22) produces the BCR‑ABL fusion gene encoding a constitutively active tyrosine kinase that drives chronic myeloid leukemia — a new, oncogenic protein product.

Net effects on protein synthesis and cell function
- Loss of function (reduced/no activity) — common in nonsense, frameshift, severe missense, deletions.
- Gain of function or novel function — some missense mutations or fusion proteins (oncogenes).
- Dominant negative — mutant protein interferes with normal protein (common in multimeric proteins).
- No effect (neutral) — many silent or conservative changes, or mutations in noncritical regions.

Bottom line
The biological consequence depends on the mutation type, its position (coding region, splice sites, regulatory sequences), and the role of the affected protein. Examples like sickle cell (missense), ΔF508 CFTR (in‑frame deletion causing misfolding), Duchenne muscular dystrophy (frameshift deletions), and BCR‑ABL (chromosomal translocation producing a novel oncogenic protein) illustrate the range of outcomes.